- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ProPhase Labs Inc (PRPH)
ProPhase Labs Inc stock price live, this page displays NASDAQ PRPH stock exchange data. View the PRPH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the ProPhase Labs Inc real time stock price chart below.
What Is the ProPhase Labs Inc Stock Price Today?
The ProPhase Labs Inc stock price today is 0.189.
What Is the Stock Symbol for ProPhase Labs Inc?
The stock symbol for ProPhase Labs Inc is ""PRPH.""
What Stock Exchange Does ProPhase Labs Inc Trade On?
ProPhase Labs Inc is listed and trades on the NASDAQ stock exchange.
Is ProPhase Labs Inc a Good Stock to Buy?
Determining whether ProPhase Labs Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PRPH quote. (ISIN: US74345W1080)
What Is the ProPhase Labs Inc Stock Price Today?
The ProPhase Labs Inc stock price today is 0.189.
What Is the Stock Symbol for ProPhase Labs Inc?
The stock symbol for ProPhase Labs Inc is ""PRPH.""
What Stock Exchange Does ProPhase Labs Inc Trade On?
ProPhase Labs Inc is listed and trades on the NASDAQ stock exchange.
Is ProPhase Labs Inc a Good Stock to Buy?
Determining whether ProPhase Labs Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PRPH quote. (ISIN: US74345W1080)
NASDAQ
Currency in USD
Fair Value
An estimate of a ProPhase Labs's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.183
0.205
52 wk Range
0.183
0.935
Trading near 52-week Low
1/2
Fair Value
An estimate of a ProPhase Labs's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.1830.205
52 wk Range
0.1830.935
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PRPH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a ProPhase Labs's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
- Form 8K ProPhase Labs Inc For: 19 November
- Investing.com
- Form 8K ProPhase Labs Inc For: 19 November
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
ProPhase Labs Inc Company Profile
ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of dietary supplements under the TK supplements, including Legendz XL, a male sexual enhancement; and Triple Edge XL, an energy and stamina booster. It also develops BE-Smart Esophageal Pre-Cancer diagnostics screening test for early detection of esophageal cancer; genomics testing technologies to analyze entire genomes, including the genes and chromosomes in deoxyribonucleic acid; DNA Expand, a platform that allows consumers to upload their DNA data from previous DNA tests obtained from other service providers; and LB-1 and LB-2 for the treatment of cancer, inflammatory diseases or symptoms and memory related syndromes, diseases or symptoms, including dementia and Alzheimer’s disease. In addition, the company provides a broad range of COVID-19 related clinical diagnostic and testing services, comprising PCR testing for COVID-19, and Influenza A and B, as well as rapid antigen testing for COVID-19. It offers its genome sequencing products to consumers online with plans to sell in food, drug, and mass retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.
ProPhase Labs Inc Earnings Call Summary for Q3/2025
- ProPhase Labs reported Q3 2025 EPS of -$0.16 (missing -$0.11 forecast) and revenue of $880,000 (84.53% below expectations), yet saw stock rise 6.59% to $0.275 premarket.
- Despite financial constraints, the company anticipates a $50 million net cash influx from Crown Medical Collections and projects a tenfold increase in value within 18 months.
- CEO Ted Karkus expressed confidence in the B-Smart Esophageal Cancer Test, claiming it 'should be worth $1 billion' within three to four years.
- The company has paused its crypto treasury strategy to focus on core business initiatives, including strategic mergers and acquisitions.
- Management addressed potential reverse stock split plans during Q&A, highlighting the disconnect between asset value and current $12 million market capitalization.
Last Updated: 19/11/2025, 21:28
Read Full TranscriptCompare PRPH to Peers and Sector
Metrics to compare | PRPH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPRPHPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.2x | −3.8x | −0.6x | |
PEG Ratio | −0.03 | −0.06 | 0.00 | |
Price/Book | 0.7x | 0.8x | 2.6x | |
Price / LTM Sales | 1.4x | 3.7x | 3.3x | |
Upside (Analyst Target) | - | 68.4% | 43.4% | |
Fair Value Upside | Unlock | 5.5% | 6.3% | Unlock |
Earnings
Latest Release
Nov 19, 2025
EPS / Forecast
-0.16 / -0.11
Revenue / Forecast
880.00K / 5.69M
People Also Watch
FAQ
What Is the ProPhase Labs (PRPH) Premarket Price Today?
The ProPhase Labs (PRPH) premarket price is 0.198. Premarket price change units: 0.006. Premarket percentage change: 3.130%. Premarket volume: 51,300.000. Current date: 22 Nov 2025. Previous close: 0.192
What Stock Exchange Does ProPhase Labs Trade On?
ProPhase Labs is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for ProPhase Labs?
The stock symbol for ProPhase Labs is "PRPH."
What Is the ProPhase Labs (PRPH) Afterhours Price Today? (Afterhours variable test: 0.196) Current Date: 22 Nov 2025
After hours price: 0.196. After hours price change (units): 0.007. Price change percentage: 3.700%
What Is the ProPhase Labs Market Cap?
As of today, ProPhase Labs market cap is 7.85M.
What Is ProPhase Labs's Earnings Per Share (TTM)?
The ProPhase Labs EPS (TTM) is -1.57.
When Is the Next ProPhase Labs Earnings Date?
ProPhase Labs will release its next earnings report on 31 Mar 2026.
From a Technical Analysis Perspective, Is PRPH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has ProPhase Labs Stock Split?
ProPhase Labs has split 2 times.
How Many Employees Does ProPhase Labs Have?
ProPhase Labs has 96 employees.
What is the current trading status of ProPhase Labs (PRPH)?
As of 22 Nov 2025, ProPhase Labs (PRPH) is trading at a price of 0.189, with a previous close of 0.192. The stock has fluctuated within a day range of 0.183 to 0.205, while its 52-week range spans from 0.183 to 0.935.
What Is the PRPH Premarket Price?
PRPH's last pre-market stock price is 0.198. The pre-market share volume is 51,300.000, and the stock has decreased by 0.006, or 3.130%.
What Is the PRPH After Hours Price?
PRPH's last after hours stock price is 0.196, the stock has decreased by 0.007, or 3.700%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.